Enhancement of Treatment Completion for Latent Tuberculosis Infection With 4 Months of Rifampin-Reference-Cited by-同舟云学术

Enhancement of Treatment Completion for Latent Tuberculosis Infection With 4 Months of Rifampin

Published:2006-12 Issue:6 Volume:130 Page:1712-1717
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Lardizabal Alfred,Passannante Marian,Kojakali Faysal,Hayden Christopher,Reichman Lee B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference17 articles.

1. Trends in tuberculosis: United States, 2004;MMWR Morb Mortal Wkly Rep,2005

2. American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection;Am J Respir Crit Care Med,2000

3. Ending neglect: the elimination of tuberculosis in the United States,2000

4. Isoniazid as preventive therapy in HIV infected intravenous drug abusers;Jordan;JAMA,1991

5. International Union Against Tuberculosis and Lung Disease;Anti-tuberculosis drug resistance in the world: report No. 3,2004

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review;Revista da Sociedade Brasileira de Medicina Tropical;2024

2. Optimising diagnosis and treatment of tuberculosis infection in community and primary care settings in two urban provinces of Viet Nam: a cohort study;BMJ Open;2023-02

3. Tuberculosis in Children;Infectious Disease Clinics of North America;2022-03

4. Outcomes of latent tuberculosis infection treatment in Istanbul;International Journal of Mycobacteriology;2022

5. Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection;Clinical Pharmacokinetics;2021-12-14